Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Targeting STAT3 signaling in kidney disease.

Pace J, Paladugu P, Das B, He JC, Mallipattu SK.

Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1151-F1161. doi: 10.1152/ajprenal.00034.2019. Epub 2019 Apr 3. Review.

PMID:
30943069
2.

Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities.

Estrada CC, Maldonado A, Mallipattu SK.

J Am Soc Nephrol. 2019 Feb;30(2):187-200. doi: 10.1681/ASN.2018080853. Epub 2019 Jan 14. Review.

3.

Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.

Guo Y, Pace J, Li Z, Ma'ayan A, Wang Z, Revelo MP, Chen E, Gu X, Attalah A, Yang Y, Estrada C, Yang VW, He JC, Mallipattu SK.

J Am Soc Nephrol. 2018 Oct;29(10):2529-2545. doi: 10.1681/ASN.2018030324. Epub 2018 Aug 24.

4.

Podocyte-Specific Loss of Krüppel-Like Factor 6 Increases Mitochondrial Injury in Diabetic Kidney Disease.

Horne SJ, Vasquez JM, Guo Y, Ly V, Piret SE, Leonardo AR, Ling J, Revelo MP, Bogenhagen D, Yang VW, He JC, Mallipattu SK.

Diabetes. 2018 Nov;67(11):2420-2433. doi: 10.2337/db17-0958. Epub 2018 Aug 16.

5.

Krüppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation.

Estrada CC, Paladugu P, Guo Y, Pace J, Revelo MP, Salant DJ, Shankland SJ, D'Agati VD, Mehrotra A, Cardona S, Bialkowska AB, Yang VW, He JC, Mallipattu SK.

JCI Insight. 2018 Jun 21;3(12). pii: 98214. doi: 10.1172/jci.insight.98214. eCollection 2018 Jun 21.

6.

The loss of Krüppel-like factor 15 in Foxd1+ stromal cells exacerbates kidney fibrosis.

Gu X, Mallipattu SK, Guo Y, Revelo MP, Pace J, Miller T, Gao X, Jain MK, Bialkowska AB, Yang VW, He JC, Mei C.

Kidney Int. 2017 Nov;92(5):1178-1193. doi: 10.1016/j.kint.2017.03.037. Epub 2017 Jun 24.

7.

Safety and Efficacy of A High Performance Graphene-Based Magnetic Resonance Imaging Contrast Agent for Renal Abnormalities.

Kanakia S, Toussaint J, Kukarni P, Lee S, Chowdhury SM, Khan S, Mallipattu SK, Shroyer KR, Moore W, Sitharaman B.

Graphene Technol. 2016 Dec;1(1):17-28. doi: 10.1007/s41127-016-0001-2. Epub 2016 Aug 3.

8.

Krüppel-like factors in mammalian stem cells and development.

Bialkowska AB, Yang VW, Mallipattu SK.

Development. 2017 Mar 1;144(5):737-754. doi: 10.1242/dev.145441. Review.

9.

The critical role of Krüppel-like factors in kidney disease.

Mallipattu SK, Estrada CC, He JC.

Am J Physiol Renal Physiol. 2017 Feb 1;312(2):F259-F265. doi: 10.1152/ajprenal.00550.2016. Epub 2016 Nov 16. Review.

10.

Reduced Krüppel-Like Factor 2 Aggravates Glomerular Endothelial Cell Injury and Kidney Disease in Mice with Unilateral Nephrectomy.

Zhong F, Mallipattu SK, Estrada C, Menon M, Salem F, Jain MK, Chen H, Wang Y, Lee K, He JC.

Am J Pathol. 2016 Aug;186(8):2021-2031. doi: 10.1016/j.ajpath.2016.03.018. Epub 2016 Jun 15.

11.

Krüppel-Like Factor 15 Mediates Glucocorticoid-Induced Restoration of Podocyte Differentiation Markers.

Mallipattu SK, Guo Y, Revelo MP, Roa-Peña L, Miller T, Ling J, Shankland SJ, Bialkowska AB, Ly V, Estrada C, Jain MK, Lu Y, Ma'ayan A, Mehrotra A, Yacoub R, Nord EP, Woroniecki RP, Yang VW, He JC.

J Am Soc Nephrol. 2017 Jan;28(1):166-184. doi: 10.1681/ASN.2015060672. Epub 2016 Jun 10.

12.

The podocyte as a direct target for treatment of glomerular disease?

Mallipattu SK, He JC.

Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F46-51. doi: 10.1152/ajprenal.00184.2016. Epub 2016 Apr 20. Review.

13.

KLF 6: a mitochondrial regulator in the kidney.

Mallipattu SK, He JC.

Oncotarget. 2015 Jun 30;6(18):15720-1. No abstract available.

14.

Serum creatinine is not the end-all, be-all of renal impairment.

Mallipattu SK, Ling J, Uribarri J.

Intern Med J. 2015 May;45(5):588. doi: 10.1111/imj.12733. No abstract available.

PMID:
25955467
15.

The beneficial role of retinoids in glomerular disease.

Mallipattu SK, He JC.

Front Med (Lausanne). 2015 Mar 23;2:16. doi: 10.3389/fmed.2015.00016. eCollection 2015. Review.

16.

Krüppel-like factor 6 regulates mitochondrial function in the kidney.

Mallipattu SK, Horne SJ, D'Agati V, Narla G, Liu R, Frohman MA, Dickman K, Chen EY, Ma'ayan A, Bialkowska AB, Ghaleb AM, Nandan MO, Jain MK, Daehn I, Chuang PY, Yang VW, He JC.

J Clin Invest. 2015 Mar 2;125(3):1347-61. doi: 10.1172/JCI77084. Epub 2015 Feb 17.

17.

Reduced Krüppel-like factor 2 expression may aggravate the endothelial injury of diabetic nephropathy.

Zhong F, Chen H, Wei C, Zhang W, Li Z, Jain MK, Chuang PY, Chen H, Wang Y, Mallipattu SK, He JC.

Kidney Int. 2015 Feb;87(2):382-95. doi: 10.1038/ki.2014.286. Epub 2014 Sep 3.

18.

Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease?

Mallipattu SK, Uribarri J.

Curr Opin Nephrol Hypertens. 2014 Nov;23(6):547-54. doi: 10.1097/MNH.0000000000000062. Review.

19.

In vivo RNA interference models of inducible and reversible Sirt1 knockdown in kidney cells.

Chuang PY, Xu J, Dai Y, Jia F, Mallipattu SK, Yacoub R, Gu L, Premsrirut PK, He JC.

Am J Pathol. 2014 Jul;184(7):1940-56. doi: 10.1016/j.ajpath.2014.03.016.

20.

Diabetic nephropathy in a nonobese mouse model of type 2 diabetes mellitus.

Mallipattu SK, Gallagher EJ, LeRoith D, Liu R, Mehrotra A, Horne SJ, Chuang PY, Yang VW, He JC.

Am J Physiol Renal Physiol. 2014 May 1;306(9):F1008-17. doi: 10.1152/ajprenal.00597.2013. Epub 2014 Mar 5.

21.

The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy.

Mallipattu SK, Salem F, Wyatt CM.

Kidney Int. 2014 Aug;86(2):259-65. doi: 10.1038/ki.2014.44. Epub 2014 Feb 26. Review.

22.

A new mechanism for albuminuria-induced podocyte injury.

Mallipattu SK, He JC.

J Am Soc Nephrol. 2013 Nov;24(11):1709-11. doi: 10.1681/ASN.2013070714. Epub 2013 Aug 29. No abstract available.

23.

Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase.

Zhong Y, Chen EY, Liu R, Chuang PY, Mallipattu SK, Tan CM, Clark NR, Deng Y, Klotman PE, Ma'ayan A, He JC.

J Am Soc Nephrol. 2013 Apr;24(5):801-11. doi: 10.1681/ASN.2012060590. Epub 2013 Apr 4.

24.

Expression of HIV transgene aggravates kidney injury in diabetic mice.

Mallipattu SK, Liu R, Zhong Y, Chen EY, D'Agati V, Kaufman L, Ma'ayan A, Klotman PE, Chuang PY, He JC.

Kidney Int. 2013 Apr;83(4):626-34. doi: 10.1038/ki.2012.445. Epub 2013 Jan 16.

25.

Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.

Mallipattu SK, He JC, Uribarri J.

Semin Dial. 2012 Sep-Oct;25(5):529-38. doi: 10.1111/j.1525-139X.2012.01081.x. Epub 2012 Apr 30. Review.

26.

Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation.

Mallipattu SK, Liu R, Zheng F, Narla G, Ma'ayan A, Dikman S, Jain MK, Saleem M, D'Agati V, Klotman P, Chuang PY, He JC.

J Biol Chem. 2012 Jun 1;287(23):19122-35. doi: 10.1074/jbc.M112.345983. Epub 2012 Apr 9.

27.

Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure.

Zhong Y, Wu Y, Liu R, Deng Y, Mallipattu SK, Klotman PE, Chuang PY, He JC.

Kidney Int. 2012 May;81(9):856-64. doi: 10.1038/ki.2011.467. Epub 2012 Jan 18.

28.

The New Epidemiology of HIV-Related Kidney Disease.

Mallipattu SK, Wyatt CM, He JC.

J AIDS Clin Res. 2012;Suppl 4:001.

29.

Methotrexate in the urine.

Mallipattu SK, Ross MJ.

Kidney Int. 2011 Jul;80(2):226. doi: 10.1038/ki.2011.97. No abstract available.

30.

Teaching surgical decision-making: an interactive, web-based approach.

Servais EL, Lamorte WW, Agarwal S, Moschetti W, Mallipattu SK, Moulton SL.

J Surg Res. 2006 Jul;134(1):102-6. Epub 2006 Feb 20.

PMID:
16488433
31.

Evidence for shear-induced increase in membrane fluidity in the dinoflagellate Lingulodinium polyedrum.

Mallipattu SK, Haidekker MA, Von Dassow P, Latz MI, Frangos JA.

J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2002 Jun;188(5):409-16. Epub 2002 May 16.

PMID:
12073085
32.

Evidence for a second valve system in lymphatics: endothelial microvalves.

Trzewik J, Mallipattu SK, Artmann GM, Delano FA, Schmid-Schönbein GW.

FASEB J. 2001 Aug;15(10):1711-7.

PMID:
11481218

Supplemental Content

Loading ...
Support Center